# Proteomic Study of Chuanhong Zhongfeng Capsule in the Treatment of ACI

> **NCT06874140** · PHASE1 · COMPLETED · sponsor: **Yingyue Ding** · enrollment: 20 (actual)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** Chuanhong Zhongfeng capsule

## Key facts

- **NCT ID:** NCT06874140
- **Lead sponsor:** Yingyue Ding
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-01
- **Primary completion:** 2025-01-01
- **Final completion:** 2025-01-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06874140

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06874140, "Proteomic Study of Chuanhong Zhongfeng Capsule in the Treatment of ACI". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT06874140. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*